For the patients shown below, if Product A had been available at the time you placed each of them onto their current treatment regimen would you have made a different treatment decision i.e. would you have used Product A instead of what they actually received?We’re specifically asking if you would have made a different decision, we are not asking if you would actively switch these patients from their current treatment to Product AClick here for a reminder of Product AClick here for a reminder about the assumptions we’ve asked you to considerDecision unchangedPatient would still have received the same treatment they didDecision changedPatient would have received Product A instead of what they actually receivedMoving on, we are now going to ask you about 3 slightly different variations of Product B. First of all, please review the following hypothetical data for Product B1.For comparison we are showing the profile for Product A alongside this.Based on the information provided, how motivated would you be to prescribe Product B1 in your patients with EGPA if it was available for you to use?